Literature DB >> 30235494

Lipid Levels Related to Osteoporosis in Patients with Type 2 Diabetes.

Yujie Wu1, Xuenong Xing1, Shandong Ye1, Chao Chen1, Jumei Wang1.   

Abstract

OBJECTIVE: Osteoporosis is a systemic skeletal disorder characterizedby reduced bone mass, deteriorated bone structure. Various studies have tried to evaluate the association between lipid level and osteoporosis, but the results were proved to be controversial. The objectives of this study are to assess the correlation between BMD and serum lipid levels, to determine independent variables associated with osteoporosis and osteopenia in men and postmenopausal women with type 2 diabetes (T2D).
MATERIALS AND METHODS: All participants of the study were carried out biochemical analysis of blood and the analysis of the lipid profile that included total cholesterol (TC) and triglyceride (TG). Physical examination and dual-energy X-ray absorptiometry examination were performed. Multiple linear regression and multivariate logistic regression were used to evaluate associations between serum TC and TG levels and the osteoporosis or osteopenia.
RESULTS: The level of serum TG was directly correlated with BMD at the lumbar spine in all patients in multiple linear regression models. After adjusting for potential confounding factors, decreased level of serum TG was independent risk factor for osteoporosis(p=0.022) in T2D patients. It also showed that a greater BMI was protective factor for osteoporosis (p=0.019) and lower level of β-CTX was an independent risk factor for osteopenia (p=0.008) and osteoporosis (p=0.001) in T2D patients.
CONCLUSION: Among Chinese patients with type 2 diabetes, the decreased level of serum TG might indicate a risk of osteoporosis. Further research is needed to confirm the finding and to clarify the contradictions identified. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2018        PMID: 30235494     DOI: 10.1055/a-0735-9361

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  2 in total

1.  Identification of hypertriglyceridemia based on bone density, body fat mass, and anthropometry in a Korean population.

Authors:  Jeong Hee Chi; Moon Sun Shin; Bum Ju Lee
Journal:  BMC Cardiovasc Disord       Date:  2019-03-22       Impact factor: 2.298

2.  Dapagliflozin Attenuates Hyperglycemia Related Osteoporosis in ZDF Rats by Alleviating Hypercalciuria.

Authors:  Ji-Yu Wang; Yan-Zhen Cheng; Shuang-Li Yang; Min An; Hua Zhang; Hong Chen; Li Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-05       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.